Skip to main content

Table 2 Average dose parameters for PTVmets according to the four planning modalities

From: Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases

 

sIMRT

dIMRT

VMAT

Tomo

p value

D2% (Gy)

50.8 ± 2.1

50.9 ± 2.4

51.4 ± 2.7

50.2 ± 2.7

> 0.05

D98% (Gy)

47.3 ± 2.5

47.6 ± 2.4

46.8 ± 2.2

46.9 ± 2.3

> 0.05

Dmedian (Gy)

49.7 ± 2.5

49.7 ± 2.5

49.7 ± 2.5

49.3 ± 2.6

> 0.05

TC (%)

99.1 ± 1.0

99.4 ± 0.7

98.9 ± 1.6

97.1 ± 1.7

c,e,f

HI

0.071 ± 0.021

0.066 ± 0.012

0.091 ± 0.024

0.065 ± 0.023

b,d,f

CI

0.74 ± 0.10

0.73 ± 0.10

0.73 ± 0.13

0.71 ± 0.10

> 0.05

  1. Each value was calculated from the data for all 10 patients. Values are expressed as mean ± SD. sIMRT step-and-shoot intensity-modulated radiotherapy, dIMRT dynamic intensity-modulated radiation therapy, VMAT volumetric-modulated arc therapy, Tomo helical tomotherapy. a: sIMRT vs dIMRT, b: sIMRT vs VMAT, c: sIMRT vs Tomo, d: dIMRT vs VMAT, e: dIMRT vs Tomo, f: VMAT vs Tomo. If c is in the “p value” column, it means that there is statistical significance between sIMRT and Tomo